Development of Strategies to Decrease False Positive Results in Newborn Screening

Abstract

by Sabrina Malvagia,Giulia Forni,Daniela Ombrone andGiancarlo la Marca
Int. J. Neonatal Screen. 2020, 6(4), 84; https://doi.org/10.3390/ijns6040084 - 15 FEB 2022
Cited by 38 | Viewed by 6059
Abstract
The expansion of national newborn screening (NBS) programmes has provided significant benefits in the diagnosis and early treatment of several rare, heritable conditions, preventing adverse health outcomes for most affected infants. New technological developments have enabled the implementation of testing panel covering over 50 disorders. Consequently, the increment of false positive rate has led to a high number of healthy infants recalled for expensive and often invasive additional testing, opening a debate about the harm-benefit ratio of the expanded newborn screening. The false-positive rate represents a challenge for healthcare providers working in NBS systems. Here, we give an overview on the most commonly used strategies for decreasing the adverse effects due to inconclusive screening results. The focus is on NBS performance improvement through the implementation of analytical methods, the application of new and more informative biomarkers, and by using post-analytical interpretive tools. These strategies, used as part of the NBS process, can to enhance the positive predictive value of the test and reduce the parental anxiety and healthcare costs related to the unnecessary tests and procedures. Full article
(This article belongs to the Special Issue Newborn Screening: Promoting Quality to Optimise Benefit and Reduce Harm)
► Show Figures
13 pages, 879 KiB
Open AccessArticle